NCT03913507View on ClinicalTrials.gov

Efficacy of a New Sweat Collection Support: Impact on Neonatal Screening and Early Treatment of Cystic Fibrosis

NACompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

July 14, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

March 22, 2021

Conditions
Cystic Fibrosis
Interventions
DEVICE

Macroduct® Advanced Model 3710 SYS, Wescor

for each subject, both methods will be tested in order to compare the efficacy of the new sweat collection method (Macroduct® Advanced Model 3710 SYS, Wescor) to the method currently used in clinical routine.

Trial Locations (1)

1200

Cliniques Universitaires St Luc, Brussels

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT03913507 - Efficacy of a New Sweat Collection Support: Impact on Neonatal Screening and Early Treatment of Cystic Fibrosis | Biotech Hunter | Biotech Hunter